A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome through a biological process closely associated with exercise.An evaluation of ...

A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects in men with prostate cancer, raising levels of a molecule tied to energy ...

Researchers have identified a surprising metabolic effect of a widely used diabetes drug in men undergoing prostate cancer treatment.

Researchers say metformin may mimic some benefits of exercise in prostate cancer patients, helping improve metabolism and manage treatment-related side effects.

A common diabetes drug may mimic one key effect of exercise in prostate cancer patients. Researchers found metformin boosts an “exercise molecule” linked to appetite and weight control, even in those ...

Prostate cancer patients treated with the widely prescribed diabetes drug metformin showed elevated blood levels of N-lactoyl-phenylalanine, or Lac-Phe, a metabolite normally produced during vigorous ...

Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment settings, while Lac-Phe itself did not predict anticancer response. Patients in ...

Members of the group are participants in LIVESTRONG at the YMCA, a 12-week conditioning program designed to help cancer ...

Discover more about how nutrition and lifestyle interventions can improve the quality of life of patients with prostate ...

With strong national and international partnerships, SETU is playing a pivotal role in shaping the future of cancer care ...

Androgen-directed therapies can precipitate weight gain, insulin resistance, and cardiovascular risk, creating a clinical need for metabolic support when fatigue, pain, or toxicity limits exercise ...